Overview
Barclays has moved Oscar Health Inc. to an "overweight" rating and lifted its price objective to $35 from $30. The upgrade rests on a thesis that artificial intelligence-related disruption of entry-level white-collar work could accelerate migration from employer-sponsored insurance toward the Individual Affordable Care Act (ACA) market, potentially making that segment the fastest-growing part of the U.S. health insurance landscape over the next five to 10 years.
Core assumption
Central to Barclays' view is a prediction cited from Anthropic chief executive Dario Amodei that "AI will disrupt 50% of entry-level white-collar jobs over 1-5 years." Barclays analysts emphasize that the key consequence may not be raw unemployment but rather the weakening of the historical link between employment and health benefits - a connection that matters because roughly half of the U.S. population receives health coverage through an employer.
Historical relationships between unemployment and employer-sponsored insurance
Barclays' report references U.S. Census data to illustrate the sensitivity of employer-sponsored insurance (ESI) enrollment to changes in unemployment. During the dot-com bust from 2000 to 2003, ESI enrollment fell 2.5% while unemployment rose 200 basis points. The Global Financial Crisis coincided with a 500-basis-point jump in unemployment and a 5.4% decline in ESI enrollment. During the COVID-19 period, an approximately 300-basis-point spike in unemployment was associated with a 2.3% decline in ESI enrollment, according to the report.
Barclays interprets these patterns as indicating that shocks to employment can produce outsized shifts in the source of coverage for many Americans, and that a structural change in the employment-coverage relationship would have material implications for health insurers.
Post-COVID enrollments and the ACA safety net
The bank points to post-COVID enrollment trends as evidence that the ACA exchanges have taken on a larger role in the U.S. safety net than Medicaid in recent years. Barclays notes that individual ACA enrollment expanded 21% from 2019 to 2021, outpacing Medicaid's 11% rise over the same period.
Forward-looking membership forecasts
Projecting forward, Barclays forecasts annual ACA exchange membership growth of 5% to 6% through 2030. By contrast, it expects Medicare Advantage to grow at 3.0% to 3.5% annually, while employer-sponsored group risk is projected to contract by 4.0% to 5.0% per year. The broker's model produces a projection of ACA enrollment reaching 24.03 million members by 2030, up from an estimated 19.44 million in 2026.
Labor market signals cited
Supporting the view that certain cohorts face elevated labor-market pressures, Barclays cites Bureau of Labor Statistics data showing graduate unemployment has risen faster than the national rate since 2023, and that employment among workers aged 16 to 24 has lagged the broader workforce. The report also highlights the increasing presence of gig work: gig workers now account for nearly 15% of total employment, up 24% since 2017, with roughly 85% of that group maintaining health insurance, per BLS data referenced in the report.
Company-level implications and valuations
On Oscar Health specifically, Barclays sets a 2028 earnings-per-share estimate of $2.74 and applies a 14x multiple, an increase from the 12x multiple used previously. The broker projects Oscar's revenue rising from $11.70 billion in 2025 to $27.37 billion in 2028, corresponding to a compound annual growth rate of 32.7% in that period.
For Centene, Barclays retains an "overweight" rating and a $75 price target, citing a bull-case scenario that includes $9.04 in upside EPS for 2028 and a potential stock value near $120 at a 13x multiple.
Cigna is identified by Barclays as the peer most exposed to potential downside from a weakening employer-coverage relationship. The bank finds Cigna has 73% of its enrollment tied to employer-sponsored insurance and a 23% concentration of revenue with technology-sector clients, the highest among the peers analyzed.
The analysis lays out how shifts in employment and benefit provision could reallocate millions of insurance enrollees across public and private markets, and how those flows translate into company-level revenue and valuation scenarios for major insurers.